Cargando…
Active pulmonary tuberculosis in a patient with secukinumab treatment
Numerous investigations have documented active tuberculosis (TB) infection following biologic treatment. One of the most secure biologic medications for infections is secukinumab. Additionally, no cases of active TB while receiving secukinumab therapy were recorded. Secukinumab 150 mg per month has...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633737/ https://www.ncbi.nlm.nih.gov/pubmed/36340221 http://dx.doi.org/10.1016/j.radcr.2022.10.032 |